Seeking Alpha

  Ampio Pharmaceuticals, Inc. - NYSEMKT

11/26/2014, 1:47 AM ET
  • IndieTrader | Send Message 25 Sep 2012

    Aegis Capital initiates coverage on Ampio Pharmaceuticals (NASDAQ: AMPE) with a Buy. PT $11.00.
      AMPE vs. ETF Alternatives
      Company Description
      Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, engaged in developing innovative, proprietary pharmaceutical drugs and diagnostic products to identify, treat and prevent human diseases including metabolic disorders, cancer etc.